DOI: http://dx.doi.org/10.18203/2349-3291.ijcp20163662

Comparison of clinical profile and severity of P. falciparum and P. vivax malaria in a tertiary care hospital of Surat, India

Poonam Singh, Nirali Mehta, Nayan G. Tada

Abstract


Background:Surat is an endemic area for malaria. There has been a change in the trend of clinical profile and severity of P.vivax and P. falciparum malaria. Initially, P. falciparum was considered notorious for its complications but now P. vivax also presents with similar pictures. Hence, vivax malaria, which was once thought to be a relatively benign condition, is appearing in its more malignant form, with severity gradually becoming a serious concern. This aim of the study is to compare the clinical profile severity of P. vivax and P. falciparum malaria in pediatrics age group in a tertiary care hospital in Surat, India.

Methods: A retrospective study was carried out at a tertiary care hospital of a medical college in Surat. This study was done for a period of 6 months from July 2014 to December 2014. Patients below 18 years of age who were smear positive for plasmodium species or malarial antigen positive were included in the study. Statistical analysis was done using chi square test for comparing proportions. P value < 0.05 was considered significant.

Results:Eighty-seven patients were found to be suffering from malaria detected by malarial antigen test or through blood smear. Out of this, 48 (55%) patients were found to have P. vivax while 31 (35.6%) patients were found to have P. falciparum and only 8 cases had mixed malaria. The common complications encountered were jaundice and severe anemia. Severe malaria was more common in patients having vivax malaria as compared to falciparum. Besides anaemia as a haematological manifestation, thrombocytopenia was the second common abnormality encountered more commonly in patients with vivax as compared to falciparum species. The detailed study morbidity profile clearly establishes that severe malaria, earlier attributed to only falciparum is equally seen in vivax.

Conclusions:Severe form of malaria is seen in vivax malaria and the age group affected by vivax also is younger. Profile of complications is different in different studies.  


Keywords


Severe malaria, Vivax, Falciparum

Full Text:

PDF

References


World health organisation, Regional office of South East Region Health topics: Malaria: World Malaria report 2014. Available at http:// www.searo. who.int/ entity/ malaria/en/. Accessed on 12 November 2014.

Estimation of true malaria burden. World Health Report, Geneva. World health Organisation 2008.

Kochar D, Saxena V, Singh N, Kochar S, Kumar V, Das A. Plasmodium vivax malaria. Emerg Infect Dis. 2005;11:132-4.

Ivo M, Galinski MR, Baird JK, Carlton JM, Kochar DK, Alonso PL, et al. 2009. Key gaps in the knowledge of plasmodium vivax, a neglected human malaria parasite. Lancet. 2009;9:555-66.

Limaye CS, Londhey VA, Nabar ST. The study of complications of vivax malaria in comparison with falciparum malaria in Mumbai. J Asso Physicians India. 2012;60:15-8.

Oduro AR, Koram KA, Rogers W, Atuguba F, Ansah P, Anyorigiya T, et al Severe falciparum malaria in young children of Kassena-Nankana district of northern Ghana. Malar J. 2007 Jul 27;6:96.

Guidelines for diagnosis and treatment of malaria in India. New Delhi, 2014. Available at http:// nvbdcp.gov.in/Doc/Diagnosis-Treatment-Malaria-2013.pdf. Accessed on 7 June 2016.

Singh R, Kumar S, Rana SK, Thakur B, Singh SP. A comparative study of clinical profiles P vivax and falciparum malaria in children in a tertiary care centre in Uttarakhand. J Clinic Diag Res. 2013;7(10):2234-7.

Verma P, Shukla US. A. Retrospective study on clinical profile of severe malaria in children admitted in a tertiary care centre of central India. People’s J Scientific Res. 2014;7(1):22-6.

World Health Organization, 2008. World Malaria Report, Geneva, Switzerland: World Health Organization. 2008.

Tripathy R , Parida S , Das L , Mishra DP , Tripathy D , Das MC , et al. Clinical manifestations and predictors of severe malaria in Indian children. Pediatrics. 2007;120:454-60.

Barcus MJ , Basri H , Picarima H , Manyakori C , Sekartuti , Elyazar I , et al. Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in northeastern Indonesian Papua . Am J Trop Med Hyg. 2007;77:984-91.

Tjitra E, Anstey NM, Saguaro P, Warikar N, Kenangalem E, Karyana M, et al. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med. 2008;5:128 .

Genton B, Acremont VD, Rare L, Baea K, Reeder JC, Alpers MP, et al. Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med. 2008;5:127.

Beg MA, Sani N, Mehraj V, Jafri W, Khan MA. Comparative features and outcomes of malaria at a tertiary care hospital in Karachi, Pakistan. Int J Infect Dis. 2008;2:37-42.

Kochar DK, Das A, Kochar SK, Saxena V, Sirohi P, garg S, et al. Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in northwestern India. Am J Trop Med Hyg. 2009;80:194-8.

Kumari M, Ghildiyal R. Clinical profile of plasmodium vivax malaria in children and study of severity parameters in relation to mortality: a tertiary care centre perspective in Mumbai, India. Malaria Res Treatment. 2014:1-6.